Repositioning of Fluoroquinolones: A New Approach in Antitumor Therapy
Biology · 30.04.2026 · 15 (9) · 717
DOI: 10.3390/biology15090717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 30.04.2026. Verfasst von Jeferson Ricardo da Silva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Keizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Federal University of Pernambuco, Brazilian National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Fluoroquinolones are known for their antibacterial properties, but recent research has revealed their potential to inhibit the growth and proliferation of cancer cells. Thus, this study aimed to emphasize the repositioning and potential of fluoroquinolones as possible therapeutic tools in the fight against cancer, opening up new perspectives for the field of oncology. Thus, this paper consists of a descriptive literature review of recent studies published between 2013 and 2023 on the use of fluoroquinolones in anticancer therapy. The results indicate that fluoroquinolones can interfere with the cell cycle, induce apoptosis and oxidative stress, and impact factors associated with tumorigenesis, such as the transcription of ectopic expression of SNAI1 for epithelial–mesenchymal transition. In addition, studies show that combining fluoroquinolones with other antineoplastic agents can increase their efficacy, and the possibility of encapsulating these drugs in controlled-release systems is also emerging as a promising antitumor strategy. In conclusion, repositioning fluoroquinolones in antitumor therapy presents an expanding field of research, offering new perspectives for cancer treatment. However, more studies are needed to fully elucidate their potential and establish effective clinical use protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Keizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil.
- Campus Ouricuri, University of Pernambuco (UPE), Ouricuri 56200-000, PE, Brazil.
- Academic Center of Vitória (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão 55608-680, PE, Brazil.
ORCID-Profile: Lara Limeira de Oliveira, Luís André de Almeida Campos, Isabella Macário Ferro Cavalcanti
Förderung
- National Council for Scientific and Technological Development
- Federal University of Pernambuco
- Brazilian National Council for Scientific and Technological Development
Zitieren
APA
da Silva, J. R., de Souza, J. B., de Oliveira, L. L., de Almeida Campos, L. A., & Cavalcanti, I. M. F. (2026). Repositioning of Fluoroquinolones: A New Approach in Antitumor Therapy. Biology, 15(9), 717. https://doi.org/10.3390/biology15090717
Vancouver
da Silva JR, de Souza JB, de Oliveira LL, de Almeida Campos LA, Cavalcanti IMF. Repositioning of Fluoroquinolones: A New Approach in Antitumor Therapy. Biology. 2026;15(9):717. doi:10.3390/biology15090717
BibTeX
@article{daSilva2026,
author = {da Silva, Jeferson Ricardo and de Souza, Jaqueline Barbosa and de Oliveira, Lara Limeira and de Almeida Campos, Luís André and Cavalcanti, Isabella Macário Ferro},
title = {Repositioning of Fluoroquinolones: A New Approach in Antitumor Therapy},
journal = {Biology},
year = {2026},
volume = {15},
number = {9},
pages = {717},
doi = {10.3390/biology15090717}
}
EUVIMED